Strides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The company will now seek final approval from the NCLT, Mumbai Bench, and listing approvals from BSE and NSE. This move aims to unlock value for stakeholders upon OneSource's listing. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
